Here at PharmaTell, we have Eyes on FDA Approvals for 2025. Below, we share the monthly Novel Drug and Biologic License Application Approval

We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.

We've had our Eyes On some of the latest Pharmaceutical news including approvals, partnering, mergers, research programs, and

This week we've had eyes on BioPharma happenings plus a 2023 Top Selling Drugs list.

We are excited to share the latest upgrades to PharmaTell Studio making it even easier for you to keep your eyes on you & your competition.

This week, the team has been looking at congress planners, earnings call transcripts, and the US FDA.

This week, the team had Eyes on the new draft guidance from the US FDA on Gene Therapy Products Incorporating Genome Editing.

Today we’ll share some of the types of reports available that can help you keep your Eyes on Pharma Sectors.